Long-term Clinical Outcomes and Predictive Factors for Living-donor Liver Transplant Recipients With Biliary Strictures

Transplantation. 2022 Oct 1;106(10):1990-1999. doi: 10.1097/TP.0000000000004201. Epub 2022 Jun 30.

Abstract

Background: Biliary strictures frequently occur in living-donor liver transplant (LDLT) recipients. However, long-term clinical outcomes and their associated factors are unclear.

Methods: We analyzed an historical cohort of 228 recipients who underwent LDLT with post-liver transplantation biliary strictures. Endoscopic retrograde cholangiography or percutaneous transhepatic biliary drainage were performed to treat biliary strictures. Patients that experienced persistent jaundice over 3 mo after the initial treatment were defined as a remission-failure group.

Results: Median observation period was 8.5 y after the diagnosis of biliary stricture. The 15-y graft survival (GS) rate was 70.6%, and 15-y rate of developing portal hypertension (PH) was 26.1%. Remission failure occurred in 25.0% of study participants. In the multivariate analysis, biopsy-proven acute rejection, and portal vein/hepatic artery abnormalities were risk factors for remission failure. Development of PH, retransplantation, and death were significantly more frequent in the remission-failure group. Remission failure and PH were associated with poor GS. In multivariate analyses, hepatic artery abnormality and biloma were common significant factors that were associated with a poor GS and development of PH.

Conclusions: The insufficient blood supply reflected by hepatic artery abnormality and biloma might be the most important factor that can predict poor long-term survival in LDLT patients with biliary strictures. Future large-scale prospective studies are needed to validate our observations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholangiopancreatography, Endoscopic Retrograde
  • Cholestasis* / diagnosis
  • Cholestasis* / etiology
  • Cholestasis* / surgery
  • Constriction, Pathologic / complications
  • Humans
  • Liver Transplantation* / adverse effects
  • Living Donors
  • Postoperative Complications / etiology
  • Retrospective Studies
  • Treatment Outcome